Discontinued — last reported Q3 '25
Non-Current Assets
Intangibles (Net)
CRCL Intangibles (Net) decreased by 62.5% to $154.19M in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ3 2025
How to read this metric
High levels reflect significant investment in growth through acquisitions; changes indicate the impact of amortization or impairment charges.
Detailed definition
This includes the value of acquired intellectual property, such as patents, trademarks, and drug licenses, net of accumu...
Peer comparison
Very high in the pharmaceutical industry due to the reliance on patent-protected drug portfolios.
Metric ID:
intangible_assets_netHistorical Data
5 periods
| Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $64.99M | $130.57M | $145.16M | $411.15M | $154.19M |
| QoQ Change | — | +100.9% | +11.2% | +183.2% | -62.5% |
| YoY Change | — | — | — | +532.6% | — |
Range$64.99M – $411.15M
CAGR+137.2%
Avg YoY Growth+532.6%
Median YoY Growth+532.6%
Intangibles (Net) at Other Companies
Frequently Asked Questions
- What is CRCL's intangibles (net)?
- CRCL (CRCL) reported intangibles (net) of $154.19M in Q1 2026.
- What does intangibles (net) mean?
- The value of non-physical assets like patents and brand names, minus their amortized cost.